Results 1 to 10 of about 76,581 (257)

Suppression of reproductive function in juvenile rams by a slow-release gonadotropin-releasing hormone implant [PDF]

open access: yesOpen Veterinary Journal, 2022
Background: Regarding animal welfare and reversible suppression of reproduction the need for alternatives to surgical castration like slow-release gonadotropin-releasing hormone implants is increasing.
Luise Prestel   +4 more
doaj   +1 more source

Invitro fertilization outcome in triggering with GnRH agonist, Hcg or combination of GnRH agonist and Hcg [PDF]

open access: yesMajallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2020
Introduction: Human chorionic gonadotropin for the final maturation of eggs in the In-vitro fertilization cycle was associated with the possibility of a negative effect on endometrial acceptance, fetal quality and ovarian hyper stimulation syndrome ...
Alamtaj Samsami   +5 more
doaj   +1 more source

Effects of gonadotropin-releasing hormone agonist treatment on final adult height in boys with idiopathic central precocious puberty [PDF]

open access: yesAnnals of Pediatric Endocrinology & Metabolism, 2021
Purpose There are few reports on the therapeutic effects of gonadotropin-releasing hormone agonists in boys with central precocious puberty, and studies reported in Korea are very rare.
Ah Young Cho   +3 more
doaj   +1 more source

Research progress of manganese exposure on abnormal GnRH release in hypothalamus affecting reproductive function

open access: yes环境与职业医学, 2023
Manganese plays an important physiological role in the organism, and excessive manganese exposure can cause impairment of neurological and reproductive functions.
Huan MAO, Yan LI
doaj   +1 more source

Obstetric and neonatal outcomes after programmed frozen embryo transfer with or without GnRH agonist for polycystic ovary syndrome: secondary analysis results from a randomized controlled trialAJOG Global Reports at a Glance

open access: yesAJOG Global Reports, 2023
BACKGROUND: Recent studies have reported higher risks of adverse maternal and neonatal outcomes, such as hypertensive disorders of pregnancy, after programmed frozen embryo transfer, especially in cycles with gonadotropin-releasing hormone agonist ...
Hui-ying Jie, MD   +6 more
doaj   +1 more source

GPGMH, a New Fixed Timed-AI Synchronization Regimen for Swamp and River Crossbred Buffaloes (Bubalus bubalis)

open access: yesFrontiers in Veterinary Science, 2021
The crossbreeding of Swamp and River type buffalo breeds is practiced for the improvement of milk yield and reproductive performance in swamp buffalo herds. This study aimed to modify the Ovsynch synchronization protocol (GPG) and improve the fixed-timed
Adili Abulaiti   +12 more
doaj   +1 more source

Fertility preservation in breast cancer with oral progestin: is it an option? A pilot study

open access: yesEinstein (São Paulo), 2021
Objective To compare the effectiveness of oral progestins and injectable gonadotropin-releasing hormone antagonist medication in cancer fertility preservation in patients with breast cancer.
Renato de Oliveira   +5 more
doaj   +2 more sources

Luteal Support and Risk of Ovarian Hyperstimulation in Assisted Reproduction (A Review)

open access: yesКубанский научный медицинский вестник, 2020
Background. Gonadotropin-releasing hormone agonist as an ovulation trigger effectively reduces the ovarian hyperstimulation risk in in vitro fertilisation protocols, at the same time requiring an effective luteal phase support in embryo transfer cycles ...
V. A. Krutova, A. A. Baklakova
doaj   +1 more source

Luteal-phase support in assisted reproductive technology: An ongoing challenge

open access: yesInternational Journal of Reproductive BioMedicine, 2021
It has been shown that in controlled ovarian hyper stimulation cycles, defective luteal phase is common. There are many protocols for improving pregnancy outcomes in women undergoing fresh and frozen in vitro fertilization cycles.
Saeideh Dashti, Maryam Eftekhar
doaj   +1 more source

Clinical applications of gonadotropin-releasing hormone analogues: a broad impact on reproductive medicine

open access: yesF&S Reports, 2023
Gonadotropin-releasing hormone (GnRH) is central to the control of the entire hypothalamic-pituitary-gonadal axis. Manipulation of GnRH, in turn, regulates pituitary response and ovarian hormone production.
Farrah L. Saleh, M.D.   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy